A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems

[1] Degenhardt L(2013)Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010 Lancet 382 1564-74

[2] Whiteford HA(2005)Benefits and costs of methadone treatment: results from a lifetime simulation model Health Econ 14 1133-50

[3] Ferrari AJ(2012)Lifetime benefits and costs of diverting substance-abusing offenders from state prison Crime Delinquency XX 1-22

[4] Zarkin GA(2005)A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting Pharmacoeconomics 23 77-91

[5] Dunlap LJ(2007)A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence Addiction 102 1899-907

[6] Hicks KA(2005)Buprenorphine, buprenorphine/naloxone and methadone maintenance: a cost-effectiveness analysis Expert Rev Pharmacoecon Outcomes Res 5 583-91

[7] Zarkin GA(2001)The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States Addiction 96 1267-78

[8] Cowell AJ(2010)Cost-utility analysis of methadone maintenance treatment in Lithuania Medicina (Kaunas) 46 286-92

[9] Hicks KA(2013)Randomized controlled trial to evaluate screening and brief intervention for drug-using multiethnic emergency and trauma department patients Addict Sci Clin Pract 8 8-513

[10] Harris AH(2014)Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial JAMA 312 502-50

[1] Degenhardt L(2013)Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010 Lancet 382 1564-74

[2] Whiteford HA(2005)Benefits and costs of methadone treatment: results from a lifetime simulation model Health Econ 14 1133-50

[3] Ferrari AJ(2012)Lifetime benefits and costs of diverting substance-abusing offenders from state prison Crime Delinquency XX 1-22

[4] Zarkin GA(2005)A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting Pharmacoeconomics 23 77-91

[5] Dunlap LJ(2007)A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence Addiction 102 1899-907

[6] Hicks KA(2005)Buprenorphine, buprenorphine/naloxone and methadone maintenance: a cost-effectiveness analysis Expert Rev Pharmacoecon Outcomes Res 5 583-91

[7] Zarkin GA(2001)The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States Addiction 96 1267-78

[8] Cowell AJ(2010)Cost-utility analysis of methadone maintenance treatment in Lithuania Medicina (Kaunas) 46 286-92

[9] Hicks KA(2013)Randomized controlled trial to evaluate screening and brief intervention for drug-using multiethnic emergency and trauma department patients Addict Sci Clin Pract 8 8-513

[10] Harris AH(2014)Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial JAMA 312 502-50